{"id":828799,"date":"2025-03-24T07:12:44","date_gmt":"2025-03-24T11:12:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/"},"modified":"2025-03-24T07:12:44","modified_gmt":"2025-03-24T11:12:44","slug":"bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/","title":{"rendered":"Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">MINNEAPOLIS<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">March 24, 2025<\/span><\/span> \/PRNewswire\/ &#8212;\u00a0Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by leveraging RNAscope technology to address unmet needs in biomarker detection and improve pathology laboratory workflows. These advancements will be highlighted in a seminar at <span class=\"xn-location\">the United States<\/span> and Canadian Academy of Pathology (USCAP) Annual Meeting taking place from <span class=\"xn-chron\">March 22-27<\/span> in <span class=\"xn-location\">Boston, MA.<\/span> Advanced Cell Diagnostics (ACD), a Bio-Techne brand, will be exhibiting and showcasing RNAscope technology at booth #222.<\/p>\n<p>Leading pathologists will describe how they have used RNAscope technology to detect clinically relevant biomarkers, including secreted proteins, point mutations and chromosomal translocations, with the potential to improve performance over existing methods and reduce time to results. The session &#8220;RNAscope: Lightning Lunch and Learn&#8221; at noon on <span class=\"xn-chron\">Tuesday, March 25<\/span>, will highlight four pathologists describing their work using RNAscope technology:<\/p>\n<ul type=\"disc\">\n<li>Dr. <span class=\"xn-person\">Rohit Mehra<\/span>, Professor of Pathology at the <span class=\"xn-org\">University of Michigan<\/span>, will describe TRIM63 mRNA as a surrogate marker in translocation-associated renal cell carcinoma, as an option to traditional DNA FISH.<\/li>\n<li>Dr. <span class=\"xn-person\">Vikram Deshpande<\/span>, Professor of Pathology at Beth Israel Deaconess Medical Center, will detail how albumin mRNA can be a superior marker to secreted protein in primary and secondary liver tumors.<\/li>\n<li>Dr. <span class=\"xn-person\">Brooke Howitt<\/span>, Associate Professor of Pathology at <span class=\"xn-org\">Stanford University<\/span>, will present advances in the <i>in situ<\/i> detection of point mutations in molecularly defined gynecologic tumors.<\/li>\n<li>Dr. <span class=\"xn-person\">Gregory Bean<\/span>, Associate Professor of Pathology at <span class=\"xn-org\">Stanford University<\/span>, will describe the direct detection of mRNA from CRTC1\/3::MAML2 translocations, as alternatives to MAML2 FISH, in the identification of mucoepidermoid carcinomas and hidradenomas.<\/li>\n<\/ul>\n<p>&#8220;We&#8217;ve made exciting advancements on <i>in situ<\/i> hybridization methods enabling novel applications in pathology laboratories,&#8221; commented Dr. <span class=\"xn-person\">Matt McManus<\/span>, President of Bio-Techne&#8217;s Diagnostics and Spatial Biology Segment. &#8220;This conference session highlights the frontier of clinical and translational research by leading pathologists using the latest RNAscope technologies for detecting the molecular underpinnings of disease.&#8221;<\/p>\n<p>\n        <i>For Research Use Only. Not intended for use in diagnostic procedures.<\/i>\n      <\/p>\n<p>\n        <b>About Bio-Techne<\/b>\n      <\/p>\n<p>Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately <span class=\"xn-money\">$1.2 billion<\/span> in net sales in fiscal 2024 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4387894-1&amp;h=1382013712&amp;u=http%3A%2F%2Fwww.bio-techne.com%2F&amp;a=http%3A%2F%2Fwww.bio-techne.com\" target=\"_blank\" rel=\"nofollow\">http:\/\/www.bio-techne.com<\/a>\u00a0or follow the Company on social media at <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4387894-1&amp;h=1169969791&amp;u=https%3A%2F%2Fwww.facebook.com%2FBioTechne&amp;a=Facebook\" target=\"_blank\" rel=\"nofollow\">Facebook<\/a>, <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4387894-1&amp;h=2238918370&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fbio-techne%2F&amp;a=LinkedIn\" target=\"_blank\" rel=\"nofollow\">LinkedIn<\/a>, <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4387894-1&amp;h=3486755108&amp;u=https%3A%2F%2Ftwitter.com%2Fbiotechne&amp;a=Twitter\" target=\"_blank\" rel=\"nofollow\">Twitter<\/a>\u00a0or <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4387894-1&amp;h=3819170772&amp;u=https%3A%2F%2Fwww.youtube.com%2F%40Bio-Techne&amp;a=YouTube\" target=\"_blank\" rel=\"nofollow\">YouTube<\/a>.<\/p>\n<p>\n        <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4387894-1&amp;h=1160937126&amp;u=https%3A%2F%2Finvestors.bio-techne.com%2Fcompany-information&amp;a=About+Bio-Techne+Corporation\" target=\"_blank\" rel=\"nofollow\">About Bio-Techne Corporation<\/a>\u00a0(NASDAQ: TECH)<br \/>Contact: <span class=\"xn-person\">David Clair<\/span>, Vice President, Investor Relations &amp; Corporate Development<br \/><a href=\"mailto:david.clair@bio-techne.com\" target=\"_blank\" rel=\"nofollow\">david.clair@bio-techne.com<\/a>\u00a0<br \/>612-656-4416<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2654\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2470019\/Bio_Techne_Corporation__logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2470019\/Bio_Techne_Corporation__logo.jpg\" title=\"BT Logo (PRNewsfoto\/Bio-Techne Corporation)\" alt=\"BT Logo (PRNewsfoto\/Bio-Techne Corporation)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CG46139&amp;sd=2025-03-24\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting-302407635.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting-302407635.html<\/a><\/p>\n<p>SOURCE  Bio-Techne Corporation<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=CG46139&amp;Transmission_Id=202503240700PR_NEWS_USPR_____CG46139&amp;DateId=20250324\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire MINNEAPOLIS , March 24, 2025 \/PRNewswire\/ &#8212;\u00a0Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by leveraging RNAscope technology to address unmet needs in biomarker detection and improve pathology laboratory workflows. These advancements will be highlighted in a seminar at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting taking place from March 22-27 in Boston, MA. Advanced Cell Diagnostics (ACD), a Bio-Techne brand, will be exhibiting and showcasing RNAscope technology at booth #222. Leading pathologists will describe how they have used RNAscope technology to detect clinically relevant biomarkers, including secreted proteins, point mutations and chromosomal translocations, with the potential to improve performance over existing methods &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-828799","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire MINNEAPOLIS , March 24, 2025 \/PRNewswire\/ &#8212;\u00a0Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by leveraging RNAscope technology to address unmet needs in biomarker detection and improve pathology laboratory workflows. These advancements will be highlighted in a seminar at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting taking place from March 22-27 in Boston, MA. Advanced Cell Diagnostics (ACD), a Bio-Techne brand, will be exhibiting and showcasing RNAscope technology at booth #222. Leading pathologists will describe how they have used RNAscope technology to detect clinically relevant biomarkers, including secreted proteins, point mutations and chromosomal translocations, with the potential to improve performance over existing methods &hellip; Continue reading &quot;Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-24T11:12:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2470019\/Bio_Techne_Corporation__logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting\",\"datePublished\":\"2025-03-24T11:12:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\\\/\"},\"wordCount\":494,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2470019\\\/Bio_Techne_Corporation__logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\\\/\",\"name\":\"Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2470019\\\/Bio_Techne_Corporation__logo.jpg\",\"datePublished\":\"2025-03-24T11:12:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2470019\\\/Bio_Techne_Corporation__logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2470019\\\/Bio_Techne_Corporation__logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting - Market Newsdesk","og_description":"PR Newswire MINNEAPOLIS , March 24, 2025 \/PRNewswire\/ &#8212;\u00a0Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by leveraging RNAscope technology to address unmet needs in biomarker detection and improve pathology laboratory workflows. These advancements will be highlighted in a seminar at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting taking place from March 22-27 in Boston, MA. Advanced Cell Diagnostics (ACD), a Bio-Techne brand, will be exhibiting and showcasing RNAscope technology at booth #222. Leading pathologists will describe how they have used RNAscope technology to detect clinically relevant biomarkers, including secreted proteins, point mutations and chromosomal translocations, with the potential to improve performance over existing methods &hellip; Continue reading \"Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-24T11:12:44+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2470019\/Bio_Techne_Corporation__logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting","datePublished":"2025-03-24T11:12:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/"},"wordCount":494,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2470019\/Bio_Techne_Corporation__logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/","name":"Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2470019\/Bio_Techne_Corporation__logo.jpg","datePublished":"2025-03-24T11:12:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2470019\/Bio_Techne_Corporation__logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2470019\/Bio_Techne_Corporation__logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-to-highlight-advances-in-the-detection-of-clinically-relevant-biomarkers-using-rnascope-technologies-at-the-2025-uscap-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/828799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=828799"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/828799\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=828799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=828799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=828799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}